Skip to search formSkip to main contentSkip to account menu

Miglustat

Known as: Miglustatum, N-Butyl deoxynojirimycin, 1,5-(butylimino)-1,5-dideoxy-D-glucitol 
A synthetic, N-alkylated imino analogue of D-glucose. Miglustat competitively and reversibly binds to and inhibits the activity of UDP-glucose… 
National Institutes of Health

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
Highly Cited
2009
Highly Cited
2009
In spite of the progress in the treatment of lysosomal storage diseases (LSDs), in some of these disorders the available… 
Highly Cited
2007
Highly Cited
2007
Dengue fever is an emerging arboviral disease for which no vaccine or antiviral treatment exists and that causes thousands of… 
Highly Cited
2002
Highly Cited
2002
ABSTRACT Endoplasmic reticulum (ER) α-glucosidase inhibitors, which block the trimming step of N-linked glycosylation, have been… 
Highly Cited
2001
Highly Cited
2001
ABSTRACT The intracellular assembly site for flaviviruses in currently not known but is presumed to be located within the lumen… 
Highly Cited
2000
Highly Cited
2000
We used a potent inhibitor of glucosylceramide synthase to test whether substrate deprivation could lower globotriaosylceramide… 
Highly Cited
1995
Highly Cited
1995
The alpha-glucosidase inhibitor N-butyldeoxynojirimycin (NB-DNJ) is a potent inhibitor of human immunodeficiency virus (HIV… 
Highly Cited
1994
Highly Cited
1994
The imino sugar N-butyldeoxynojirimycin (NBDNJ) is a potent inhibitor of the oligosaccharide-trimming enzyme alpha-glucosidase I… 
Highly Cited
1988
Highly Cited
1988
Recent data suggest that aminosugar derivatives which inhibit glycoprotein processing have potential anti-human immunodeficiency…